Superoxide dismutase A antigens derived from molecular analysis of sarcoidosis granulomas elicit systemic Th-1 immune responses

Respiratory Research

Volumn 9, Issue , 2008, Pages

  Allen, Shannon S ^a   Evans, Whitney ^a   Carlisle, James ^a   Hajizadeh, Rana ^a   Nadaf, Michele ^a   Shepherd, Bryan E ^a   Pride, David T ^b   Johnson, Joyce E ^a   Drake, Wonder P ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; BACTERIAL ANTIGEN; BACTERIAL PROTEIN; SODA PROTEIN, BACTERIA; SUPEROXIDE DISMUTASE;

ARTICLE; FEMALE; GRANULOMA; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; SARCOIDOSIS; TH1 CELL;

ANTIGENS; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; FEMALE; GRANULOMA; HUMANS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; SARCOIDOSIS; SUPEROXIDE DISMUTASE; TH1 CELLS;

EID: 44449130564     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-9-36     Document Type: Article

References (26)

1. Baughman RP, Teirstein AS, Judson MA, Rossman MD, Yeager H, Brenitz EA, Depalo L, Hunninghake G, Iannuzzi MC, Johns CJ, MCLennan G, Moller DR, Newman LS, Rabin DL, Rose C, Rybicki B, Weinberger SE, Terrin ML, Knatterrud GL, Cherniak R, . A Case Control Etiologic Study of Sarcoidosis Group Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 2001, 164:1885-9. A Case Control Etiologic Study of Sarcoidosis Group.
2. Newman LS. Metals that cause sarcoidosis. Semin Respir Infect 1998, 13:212-20.
3. Rose C. Hypersensitivity pneumonitis. Occupational and environmental respiratory disease 1996, 201-215. Mosby Year Book, Inc., St. Louis, Harber P, Schenker M, Balmes J.
4. Scadding JG, Mitchell DN. Sarcoidosis. 1985, 36-41. London: Chapman and Hall, 2.
5. Drake WP, Pei Z, Pride DT, Collins RD, Cover TL, Blaser MJ. Molecular analysis of sarcoidosis and control tissues for Mycobacteria DNA. Emerg Infect Dis 2002, 8:1328-1335.
6. Song Z, Marzilli L, Greenlee BM, Chen ES, Silver RF, Askin FB, Teirstein AS, Zhang Y, Cotter RJ, Moller DR. Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis. J Experimental Med 2005, 201(5):755-67. 10.1084/jem.20040429, 15753209, 2212832.
7. Dubaniewicz A, Kampfer S, Singh M. Serum anti-mycobacterial heat shock proteins antibodies in sarcoidosis and tuberculosis. Tuberculosis 2005, 86:60-67.
8. Dubaniewicz A, Dubaniewicz-Wybieralska M, Sternau A, Zwolska Z, Izycka-Swieszewska E, Augustynowicz-Kopec E, Skokowski J, Singh M, Zimnoch L. Mycobacterium tuberculosis Complex and Mycobacterial Heat Shock Proteins in Lymph Node Tissue from Patients with Pulmonary Sarcoidosis. J Clin Microbiol 2006, 44:3448-3451. 1594733, 16954298, 10.1128/JCM.01433-06.
9. Drake WP, Dhason MS, Nadaf M, Shepherd BE, Vivedulu S, Hajizadeh R, Newman LS, Kalams SA. Cellular recognition of Mycobacterium ESAT-6 and katG peptides in systemic sarcoidosis. Infect Immun 2007, 75:525-530.
10. Harth G, Horwitz MA. Export of recombinant Mycobacterium tuberculosis superoxide dismutase is dependent upon both information in the protein and mycobacterial export machinery. A model for studying export of leaderless proteins by pathogenic mycobacteria. J Biol Chem 1999, 274:4281-4292. 10.1074/jbc.274.7.4281, 9933629.
11. Zhang Y, Lathigra R, Garbe T, Catty D, Young D. Genetic analysis of superoxide dismutase, the 23 kilodalton antigen of Mycobacterium tuberculosis. Mol Microbiol 1991, 5:381-391. 10.1111/j.1365-2958.1991.tb02120.x, 1904126.
12. Andersen P. The T Cell Response to Secreted Antigens of Mycobacterium tuberculosis. Immunobiol 1994, 191:537-547.
13. Zolg JW, Philippi-Schulz S. The Superoxide Dismutase Gene, a Target for detection and identification of mycobacteria by PCR. J Clin Microbiol 1994, 32:2801-12. 264162, 7852575.
14. Carlisle J, Evans W, Hajizadeh R, Richter K, Drake WP. "Immune recognition of multiple mycobacterial antigens by sarcoidosis subjects.". J Clin Exp Immunol 2007, 150:460-8.
15. Altfeld MA, Livingston B, Reshamwala N. Identification of novel HLA-A2-restricted human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte epitopes predicted by the HLA-A2 supertype peptide-binding motif. J Virol 2001, 75:1301-311. 114036, 11152503, 10.1128/JVI.75.3.1301-1311.2001.
16. Cosma CL, Humbert O, Ramakrishnan L. Superinfecting mycobacteria home to established tuberculous granulomas. Nature Immunol 2004, 5:828-35. 10.1038/ni1091, 15220915.
17. Pathan AA, Wilkinson KA, Klenerman P, McShane H, Davidson RN, Pasvol G, Hill AV, Lalvani A. Direct ex vivo analysis of antigen-specific IFN-gamma-secreting CD4 T cells in Mycobacterium tuberculosis-infected individuals: associations with clinical disease state and effect of treatment. J Immunol 2001, 167:5217-25.
18. Zhang Y, Garcia MJ, Lathigra R, Allen B, Moreno C, A Van Emden JD, Young D. Alterations in the Superoxide Dismutase Gene of an Isoniazid-Resistant Strain of Mycobacterium tuberculosis. Infect Immun 1992, 60:2160-5. 257138, 1587584.
19. Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, Schwieterman WD, Siegel JN, Braun MM. Tuberculosis associated with infliximab, a TNF-á-neutralizing agent. N Engl J Med 2001, 345:1098-1104. 10.1056/NEJMoa011110, 11596589.
20. Arnow PM, Bakir M, Thompson K, Bova JL. Endemic contamination of clinical specimens by Mycobacterium gordonae. Clin Infect Dis 2000, 31:472-6. 10.1086/313940, 10987707.
21. Brown NM, Hellyar EA, Harvey JE, Reeves DS. Mycobacterial contamination of fibreoptic bronchoscopes. Thorax 1993, 48:1283-5. 465001, 8303642.
22. Muller-Quernheim J, Gaede KI, Fireman E, Zissel G. Diagnoses of chronic beryllium disease within cohorts of sarcoidosis patients. Eur Respir J 2006, 27:1190-5. 10.1183/09031936.06.00112205, 16540500.
23. Aiken AM, Hill A Fox PC, McAdam KP, Jackson-Sillah D, Lugos MD, Donkor SA, Adegbola RA, Brookes RH. Reversion of the ELISPOT test after treatment in Gambian tuberculosis cases. BMC Infectious Diseases 2006, 6:66. 1562425, 16573826, 10.1186/1471-2334-6-66.
24. Mazurek GH, Philip LoBue A, Daley CL, Bernardo J, Lardizabal AA, Bishai WR, Iademarco MF, Rothel JS. Comparison of a Whole-Blood Interferon γ Assay With Tuberculin Skin Testing for Detecting Latent Mycobacterium tuberculosis Infection. JAMA 2001, 286:1740-1747. 10.1001/jama.286.14.1740, 11594899.
25. Mustafa AS. HLA-restricted immune response to mycobacterial antigens: relevance to vaccine design. Hum Immunol 2000, 61:166-71. 10.1016/S0198-8859(99)00137-8, 10717810.
26. Ravn P, Munk ME, Andersen AB, Lundgren B, Lundgren JD JD, Nielsen LN, Kok-Jensen A, Andersen P, Weldingh K. Prospective evaluation of a whole-blood test using Mycobacterium tuberculosis-specific antigens ESAT-6 and CFP-10 for diagnosis of active tuberculosis. Clin & Diag Lab Immunol 2005, 12:491-6.